Alzheimer's disease--clinical trials and the logic of clinical purpose - PubMed (original) (raw)
Editorial
. 2006 Oct 12;355(15):1604-6.
doi: 10.1056/NEJMe068163.
- PMID: 17035654
- DOI: 10.1056/NEJMe068163
Editorial
Alzheimer's disease--clinical trials and the logic of clinical purpose
Jason Karlawish. N Engl J Med. 2006.
No abstract available
Comment in
- Atypical antipsychotic drugs and Alzheimer's disease.
Hussain HM, Hotopf M, Oyebode F. Hussain HM, et al. N Engl J Med. 2007 Jan 25;356(4):416; author reply 417-8. doi: 10.1056/NEJMc063094. N Engl J Med. 2007. PMID: 17251541 Retracted. No abstract available.
Comment on
- Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.
Schneider LS, Tariot PN, Dagerman KS, Davis SM, Hsiao JK, Ismail MS, Lebowitz BD, Lyketsos CG, Ryan JM, Stroup TS, Sultzer DL, Weintraub D, Lieberman JA; CATIE-AD Study Group. Schneider LS, et al. N Engl J Med. 2006 Oct 12;355(15):1525-38. doi: 10.1056/NEJMoa061240. N Engl J Med. 2006. PMID: 17035647 Clinical Trial.
Similar articles
- Atypical antipsychotic drugs and Alzheimer's disease.
Hussain HM, Hotopf M, Oyebode F. Hussain HM, et al. N Engl J Med. 2007 Jan 25;356(4):416; author reply 417-8. doi: 10.1056/NEJMc063094. N Engl J Med. 2007. PMID: 17251541 Retracted. No abstract available. - Atypical antipsychotic drugs and Alzheimer's disease.
Jockers-Scherübl MC, Hellweg R. Jockers-Scherübl MC, et al. N Engl J Med. 2007 Jan 25;356(4):416-7; author reply 417-8. N Engl J Med. 2007. PMID: 17256186 No abstract available. - Psychopharmacology of noncognitive abnormal behaviors in Alzheimer's disease.
Raskind MA. Raskind MA. J Clin Psychiatry. 1998;59 Suppl 9:28-32. J Clin Psychiatry. 1998. PMID: 9720484 Review. - Are atypical antipsychotics safe in patients with Alzheimer's disease?
Jones SS. Jones SS. Am Fam Physician. 2006 Aug 1;74(3):414. Am Fam Physician. 2006. PMID: 16913159 Review. No abstract available. - The art of prescribing: pharmacological management of psychosis in Alzheimer's disease: clinical challenges associated with second-generation antipsychotic medications.
Antai-Otong D. Antai-Otong D. Perspect Psychiatr Care. 2008 Apr;44(2):120-3. doi: 10.1111/j.1744-6163.2008.00161.x. Perspect Psychiatr Care. 2008. PMID: 18366366 Review. No abstract available.
Cited by
- Why do so many drugs for Alzheimer's disease fail in development? Time for new methods and new practices?
Becker RE, Greig NH, Giacobini E. Becker RE, et al. J Alzheimers Dis. 2008 Oct;15(2):303-25. doi: 10.3233/jad-2008-15213. J Alzheimers Dis. 2008. PMID: 18953116 Free PMC article. Review. - Mexiletine therapy for chronic pain: survival analysis identifies factors predicting clinical success.
Carroll IR, Kaplan KM, Mackey SC. Carroll IR, et al. J Pain Symptom Manage. 2008 Mar;35(3):321-6. doi: 10.1016/j.jpainsymman.2007.04.022. Epub 2008 Jan 28. J Pain Symptom Manage. 2008. PMID: 18222627 Free PMC article. - Documentation of antipsychotic use and indications for newly diagnosed, nonaggressive dementia patients.
Dhawan N, Steele AB, Morgan RO, Snow AL, Davila JA, Kunik ME. Dhawan N, et al. Prim Care Companion J Clin Psychiatry. 2008;10(2):97-102. doi: 10.4088/pcc.v10n0202. Prim Care Companion J Clin Psychiatry. 2008. PMID: 18458729 Free PMC article. - Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials.
Raschetti R, Albanese E, Vanacore N, Maggini M. Raschetti R, et al. PLoS Med. 2007 Nov 27;4(11):e338. doi: 10.1371/journal.pmed.0040338. PLoS Med. 2007. PMID: 18044984 Free PMC article. Review. - Neuropsychiatric clinical trials: should they accommodate real-world practices or set standards for clinical practices?
Becker RE, Greig NH. Becker RE, et al. J Clin Psychopharmacol. 2009 Feb;29(1):56-64. doi: 10.1097/JCP.0b013e318192e2fa. J Clin Psychopharmacol. 2009. PMID: 19142109 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical